Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-068524
Filing Date
2026-06-15
Accepted
2026-06-15 08:42:17
Documents
2
Period of Report
2026-06-15

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0294746-6k_newcelx.htm 6-K 10704
2 PRESS RELEASE TITLED: "NEWCELX PUBLISHES PEER-REVIEWED STUDY DEMONSTRATING BROAD ea029474601ex99-1.htm EX-99.1 16030
  Complete submission text file 0001213900-26-068524.txt   27924
Mailing Address THE CIRCLE 6 8058 ZURICH Switzerland
Business Address THE CIRCLE 6 8058 ZURICH Switzerland 41-41-618-80-00
NewcelX Ltd. (Filer) CIK: 0001783036 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39957 | Film No.: 261089149
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)